Lisa Rydén

Professor, consultant, Senior Consultant SurgeryKnown as name: Lisa Ryden
More filtering options
  1. 2021
  2. Tumor co-expression of progranulin and sortilin as a prognostic biomarker in breast cancer

    Karoline Berger, Sara Rhost, Svanheiður Rafnsdóttir, Éamon Hughes, Ylva Magnusson, Maria Ekholm, Olle Stål, Lisa Rydén & Göran Landberg, 2021, In: BMC Cancer. 21, 1, 185.

    Research output: Contribution to journalArticle

  3. 2020
  4. Added value of contrast-enhanced mammography (CEM) in staging of malignant breast lesions - A feasibility study

    Kristina Åhsberg, Anna Gardfjell, Emma Nimeus, Rogvi Rasmussen, Catharina Behmer, Sophia Zackrisson & Lisa Ryden, 2020 May 21, In: World Journal of Surgical Oncology. 18, 100.

    Research output: Contribution to journalArticle

  5. Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression

    Charlotte Levin Tykjær Jørgensen, Carina Forsare, Pär Ola Bendahl, Anna Karin Falck, Mårten Fernö, Kristina Lövgren, Kristina Aaltonen & Lisa Rydén, 2020 Apr 16, In: Breast Cancer Research and Treatment. 181, 2, p. 369-381 13 p.

    Research output: Contribution to journalArticle

  6. Barriers and facilitators for individualized rehabilitation during breast cancer treatment- A focus group study exploring health care professionals' experiences

    Ulrika Olsson Möller, Ing-Marie Olsson, Katarina Sjövall, Ingela Beck, Lisa Rydén & Marlene Malmström, 2020 Mar 26, In: BMC Health Services Research. 20, 252.

    Research output: Contribution to journalArticle

  7. Whole-genome sequencing of triple negative breast cancers in a standard population-based clinical setting

    Johan Staaf, Dominik Glodzik, Ana Bosch Campos, Johan Vallon-Christersson, Christel Reuterswärd, Jari Häkkinen, Andrea Degasperi, Tauanne Dias Amarante, Lao Saal, Cecilia Hegardt, Hilary Stobart, Anna Ehinger, Christer Larsson, Lisa Ryden, Niklas Loman, Martin Malmberg, Anders Kvist, Hans Ehrencrona, Helen R. Davies, Åke Borg & 1 others, Serena Nik-Zainal, 2020 Feb 6, In: Breast Cancer Research and Treatment. 180, p. 531-532

    Research output: Contribution to journalPublished meeting abstract

  8. The generalisability of randomised clinical trials: an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer

    Jana de Boniface, Johan Ahlgren, Yvette Andersson, Leif Bergkvist, Jan Frisell, Dan Lundstedt, Roger Olofsson Bagge, Lisa Rydén, Malin Sund & the SENOMAC Trialists’ Group the SENOMAC Trialists’ Group, 2020 Feb, In: Breast Cancer Research and Treatment. 180, 1, p. 167-176 10 p.

    Research output: Contribution to journalArticle

  9. 2019
  10. Refinement of breast cancer molecular classification by miRNA expression profiles

    Rolf Søkilde, Helena Persson, Anna Ehinger, Anna Chiara Pirona, Mårten Fernö, Cecilia Hegardt, Christer Larsson, Niklas Loman, Martin Malmberg, Lisa Rydén, Lao Saal, Åke Borg, Johan Vallon-Christerson & Carlos Rovira, 2019 Jun 17, In: BMC Genomics. 20, 1, 12 p., 503.

    Research output: Contribution to journalArticle

  11. A comprehensive approach to rehabilitation interventions following breast cancer treatment - a systematic review of systematic reviews

    U Olsson Möller, I Beck, L Rydén & M Malmström, 2019 May 20, In: BMC Cancer. 19, 472.

    Research output: Contribution to journalReview article

  12. Effects of adjuvant tamoxifen over three decades on breast cancer–free and distant recurrence–free interval among premenopausal women with oestrogen receptor–positive breast cancer randomised in the Swedish SBII:2pre trial

    M. Ekholm, P. O. Bendahl, M. Fernö, B. Nordenskjöld, O. Stål, L. Rydén & South Swedish and South-East Swedish Breast Cancer Groups South Swedish and South-East Swedish Breast Cancer Groups, 2019, In: European Journal of Cancer. 110, p. 53-61 9 p.

    Research output: Contribution to journalArticle

  13. Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study

    Johan Staaf, Dominik Glodzik, Ana Bosch, Johan Vallon-Christersson, Christel Reuterswärd, Jari Häkkinen, Andrea Degasperi, Tauanne Dias Amarante, Lao H Saal, Cecilia Hegardt, Hilary Stobart, Anna Ehinger, Christer Larsson, Lisa Rydén, Niklas Loman, Martin Malmberg, Anders Kvist, Hans Ehrencrona, Helen R Davies, Åke Borg & 1 others, Serena Nik-Zainal, 2019, In: Nature Medicine. 25, p. 1526–1533

    Research output: Contribution to journalArticle

  14. 2018
  15. Non-linear transformations of age at diagnosis, tumor size, and number of positive lymph nodes in prediction of clinical outcome in breast cancer

    Carina Forsare, Martin Bak, Anna Karin Falck, Dorthe Grabau, Fredrika Killander, Per Malmström, Lisa Rydén, Olle Stål, Marie Sundqvist, Pär Ola Bendahl & Mårten Fernö, 2018 Dec 7, In: BMC Cancer. 18, 1, 1226.

    Research output: Contribution to journalArticle

  16. Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling

    Pernilla Roswall, Matteo Bocci, Michael Bartoschek, Hong Li, Glen Kristiansen, Sara Jansson, Sophie Lehn, Jonas Sjölund, Steven Reid, Christer Larsson, Pontus Eriksson, Charlotte Anderberg, Eliane Cortez, Lao H Saal, Christina Orsmark-Pietras, Eugenia Cordero, Bengt Kristian Haller, Jari Häkkinen, Ingrid J G Burvenich, Elgene Lim & 7 others, Akira Orimo, Mattias Höglund, Lisa Rydén, Holger Moch, Andrew M Scott, Ulf Eriksson & Kristian Pietras, 2018 Mar 12, In: Nature Medicine. 24, p. 463–473

    Research output: Contribution to journalArticle

Previous 1 2 3 4 Next